Thursday, January 21, 2016 10:57:25 AM
https://www.b2match.eu/cytosorbusersmeeting2016/pages/agenda
Hotel Marivaux, Brussels, Belgium
Begin:
03/14/2016
End:
03/14/2106
Program
12:00 am Registration and lunch buffet / Bilateral meetings
1:00 pm Opening
C Steiner, CytoSorbents Europe
1:10 pm Introduction to the CytoSorb Therapy
J Kellum, Pittsburgh, USA
1:30 pm Clinical studies and experiences in sepsis
Chair: A Grootendorst, Rotterdam, Netherlands & J Kellum, Pittsburgh, USA
1:30 pm Early cytokine adsorption in septic shock: The ACCES trial
Z Molnar, Szeged, Hungary
1:45 pm Outcome observations in early vs late use in septic shock patients
M Drüner, Emden, Germany
1:55 pm Treatment experience in various types of septic shock
A Grootendorst, Rotterdam, Netherlands
2:05 pm Impact of CytoSorb on antibiotic levels in septic patients
D Kindgen-Milles, Düsseldorf, Germany
2:20 pm Discussion and Summary
2:50 pm Coffee break / Bilateral meetings
3:20 pm Clinical studies and experiences in cardiac surgery
Chair: X Monnet, Paris, France & D Kindgen-Milles, Düsseldorf, Germany
3:20 pm CytoSorb in cardiac surgery: background, rationale and first data
AC Deppe, Cologne, Germany
3:35 pm Experiences with intraoperative CytoSorb treatment in cardiac surgery
G Peeters, Angers, France
3:45 pm Discussion and summary
4:10 pm Clinical experiences from various fields of application
Chair: D Tomescu, Bucharest, Romania & A Nierhaus, Hamburg, Germany
4:10 pm Quantification and kinetics of bilirubin removal with CytoSorb
S Faenza, Bologna, Italy
4:20 pm CytoSorb treatments in patients with H1N1 infection
A Ansari, Leelavathi, India
4:30 pm Role of CytoSorb in the therapy of severe acute pancreatitis
A Faltlhauser, Weiden, Germany
4:40 pm Experience of CytoSorb in patients with septic shock: a retrospective analysis
M Yilmaz, Gaziantep, Turkey
4:50 pm Treatment support of rhabdomyolysis patients by CytoSorb
D Fries, Innsbruck, Austria
5:00 pm Discussion and summary
5:30 pm Coffee break
5:45 pm Panel discussion and take home messages
Moderator: Z Molnar
Panelists: J Kellum, A Grootendorst, AC Deppe
6:15 pm Closing remarks
P Chan, CEO CytoSorbents Corporation
6:30 pm Bilateral meetings
8:00 pm Dinner
http://cytosorb-therapy.com/event/3rd-international-users-meeting/
Recent CTSO News
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:51:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:58:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:57:45 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/16/2024 09:28:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 09:12:04 PM
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/16/2024 08:05:00 PM
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results • GlobeNewswire Inc. • 08/13/2024 08:19:55 PM
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer • GlobeNewswire Inc. • 08/13/2024 08:18:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:04:32 PM
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:12:56 PM
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/26/2024 09:14:03 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 09:11:21 PM
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress • GlobeNewswire Inc. • 07/17/2024 11:00:00 AM
- CytoSorbents Secures $20 Million Credit Facility • GlobeNewswire Inc. • 07/02/2024 11:00:00 AM
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM